J&J Pours $1B into Jacksonville to Boost U.S. Contact Lens Production
Event summary
- J&J investing $1B+ in Jacksonville, Florida to expand Vision manufacturing, packaging, and distribution.
- New state-of-the-art facility expected to be operational by 2028.
- Investment part of J&J's $55B U.S. manufacturing, R&D, and tech commitment through early 2029.
- J&J manufactures 1.7B ACUVUE contact lenses annually in Jacksonville.
- Company contributes $6B annually to Florida's economy.
The big picture
J&J's $1B investment in Jacksonville underscores a broader trend of healthcare companies reshoring critical manufacturing to the U.S. This move aligns with the company's $55B commitment to domestic operations, reflecting both strategic and political pressures to strengthen U.S. supply chains. The investment also highlights the growing importance of Florida as a hub for advanced manufacturing and life sciences innovation.
What we're watching
- Supply Chain Resilience
- Whether J&J can sustain this level of domestic investment amid global supply chain volatility.
- Regulatory Dynamics
- How state and federal incentives shape future healthcare manufacturing investments in Florida.
- Execution Risk
- The pace at which J&J can scale production to meet growing demand for ACUVUE lenses.
Related topics